Sedia Biosciences Corp.’s Post

View organization page for Sedia Biosciences Corp., graphic

1,016 followers

Health inequities disproportionately affect Black people and other historically marginalized groups, hindering their access to HIV prevention, treatment and care services. The National Institute of Allergy and Infectious Diseases (NIAID) highlights this issue in their article released on the 25th anniversary of National Black HIV/AIDS Awareness Day, Working Together to End HIV in Black Communities - https://lnkd.in/gATws8rn   At Sedia, we're committed to advancing access to care and improving the lives of those affected by HIV. Asante® Rapid Recency enables detection of recent HIV infection at the point of care, helping to identify populations with high HIV transmission. The NIAID article highlights community engagement, education, and empowerment as critical elements for achieving public health goals. Rapid Recency can contribute to these efforts by: 1️⃣ Recency testing complements standard HIV diagnostic testing, providing information for better understanding of where new infections occur which can further support HIV prevention, treatment, and care efforts. 2️⃣ HIV recency testing data can inform targeted, population-level HIV prevention and testing interventions.   By leveraging technology and innovation in the Asante Rapid Recency test, Sedia is working to help end the HIV epidemic, including for disproportionately affected individuals and groups.   To learn more about how Sedia and Asante Rapid Recency are contributing to the efforts to end AIDS, reach out to us or visit our website - https://lnkd.in/dca2szd5. Together we make a difference, let's unite in the fight against HIV/AIDS! #hivawareness #hivaids #NIAID

Working Together to End HIV in Black Communities

Working Together to End HIV in Black Communities

niaid.nih.gov

To view or add a comment, sign in

Explore topics